These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 373396)

  • 1. Haemodynamic parameters in hypertensive patients treated with a diuretic and with a diuretic in combination with a beta-blocker.
    Harvald B; Fabricius J; Thomsen A
    Acta Med Scand Suppl; 1979; 625():22-5. PubMed ID: 373396
    [No Abstract]   [Full Text] [Related]  

  • 2. An evaluation of debrisoquine and mefruside in the treatment of hypertension in African and Indian patients.
    Seedat YK
    Curr Med Res Opin; 1980; 7(1):68-72. PubMed ID: 7428417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrendipine and mefruside in elderly hypertensives: effects on blood pressure, cardiac output, cerebral blood flow and metabolic parameters.
    Landmark K; Forsman M; Lindberg K; Ryman T; Martmann-Moe K; Haaverstad S; Wiel S
    J Hum Hypertens; 1995 Apr; 9(4):281-5. PubMed ID: 7595911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled, crossover trial to investigate the additive hypotensive effect of a diuretic (mefruside) to that produced by nifedipine.
    Poulter N; Thompson AV; Sever PS
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S53-6. PubMed ID: 2455140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical assay of a debrisoquine-diuretic compound when treating moderate arterial hypertension (author's transl)].
    Mérier GR; Baczko A
    Schweiz Rundsch Med Prax; 1979 Aug; 68(35):1123-8. PubMed ID: 504071
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemodynamic effects of saluretic treatment and beta-receptor blockade in patients with essential hypertension.
    Bevegård S; Castenfors J; Danielson M
    Acta Med Scand; 1977 Jan; 201(1-2):99-104. PubMed ID: 835380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and statistical considerations on a new drug in the therapy of arterial hypertension. Controlled study].
    Antognetti R; Giovine GG
    Minerva Cardioangiol; 1984 May; 32(5):313-23. PubMed ID: 6382056
    [No Abstract]   [Full Text] [Related]  

  • 8. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
    Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mild and medium severe hypertension. Treatment of mild and medium severe hypertension with bendigon mite].
    Schnicke M; Olschowka U; Rezori R
    ZFA (Stuttgart); 1979 Mar; 55(7):462-5. PubMed ID: 371178
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemodynamic effects of four months' mefruside therapy in hypertensive patients.
    Bevegård S; Castenfors J; Danielson M
    Acta Med Scand; 1977 Jan; 201(1-2):93-7. PubMed ID: 835379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new guanabenz-mefruside drug in the treatment of arterial hypertension].
    Buemi M; Macrì I; Ussi F; Frisina N
    Minerva Cardioangiol; 1985; 33(1-2):73-80. PubMed ID: 4010975
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of idiopathic hypertension with guanabenz-mefruside].
    Tomasi AM; Pirani R; Masoni C
    Minerva Cardioangiol; 1984 May; 32(5):339-44. PubMed ID: 6382059
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of acebutolol combined with mefruside on total-body and serum potassium in essential hypertensive patients.
    Schulte KL; Meyer-Sabellek W; Gotzen R
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):438-40. PubMed ID: 6490227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nifedipine and mefruside on renal function and platelet function in hypertensive patients.
    Notghi A; Fiskerstrand CE; Burnet ME; Anderton JL
    Curr Med Res Opin; 1987; 10(7):441-9. PubMed ID: 3621989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of arterial hypertension with a new drug combining guanabenz-mefruside].
    Frisina N; Macrì I; Ussi F
    Minerva Cardioangiol; 1984 May; 32(5):325-32. PubMed ID: 6382057
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of nifedipine and propranolol used in combination with diuretics for the treatment of hypertension.
    Zusman R; Christensen D; Federman E; Kochar MS; McCarron D; Porush JG; Spitalewitz S
    Am J Med; 1987 Mar; 82(3B):37-41. PubMed ID: 3551602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of a drug combination for antihypertensive therapy in general practice].
    Voigt U
    Med Welt; 1981 Sep; 32(37):1368-74. PubMed ID: 7029196
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mechanism of hypotensive action of a diuretic, mefruside, based on the pressure-natriuresis relationship].
    Saito F; Kimura G; Shimozaki Y; Fujii T; Ishii T; Yoshida K; Abe H; Kawamura M; Deguchi F; Kawano Y
    Nihon Jinzo Gakkai Shi; 1987 Apr; 29(4):461-7. PubMed ID: 3656703
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of nifedipine (retard formulation) and mefruside in the treatment of mild to moderate hypertension--a prospective randomized double-blind crossover study in general practice.
    Douglas-Jones AP; Mitchell AD
    Postgrad Med J; 1984 Aug; 60(706):529-32. PubMed ID: 6382224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effects of low-dose captopril plus a thiazide diuretic on mild to moderate essential hypertension: a multicenter double-blind comparison with propranolol. Captopril Research Group of Japan.
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S77-81. PubMed ID: 2580181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.